JAMES LIBECCO: Open Payments
NPI 1215991393 · FAIRLAWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168,280 in 226 payments from 21 companies in 2025. Trend: 2023 $174,047 · 2024 $248,982 · 2025 $168,280
Speaker / faculty: $139,245Consulting: $9,960Travel & lodging: $6,348Speaker / faculty: $4,840Food & beverage: $4,654Honoraria: $3,190
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 41 | $48,594 |
| UCB, Inc. | 33 | $40,001 |
| ABBVIE INC. | 52 | $26,503 |
| Lilly USA, LLC | 20 | $20,450 |
| Galderma Laboratories, L.P. | 14 | $10,228 |
| Novartis Pharmaceuticals Corporation | 13 | $9,404 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $6,874 |
| Organon LLC | 7 | $3,364 |
| E.R. Squibb & Sons, L.L.C. | 11 | $2,000 |
| MERZ NORTH AMERICA, INC. | 1 | $199 |
Products named: TREMFYA, Bimzelx, EBGLYSS, RINVOQ, SKYRIZI, NEMLUVIO, ILUMYA, VTAMA.
Industry payments across OH — which companies pay providers there.
